Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top
Full FDA approval: Is vaccine stock a buy?
Views 430K Contents 130

Daily Poll: 1+1= Stonk? Moderna stock jumped 7% after unveiling new vaccine.

Daily Poll: 1+1= Stonk? Moderna stock jumped 7% after unveiling new vaccine.
$MRNA.US$ stock gained 7.8% Thursday, its virtual R&D day, which began at 8 a.m. Eastern. It plans to announce the development of a vaccine candidate that will protect against Covid-19 and the flu, to be known as mRNA-1073. 
Moderna was a very different company at the time of its last virtual R&D day in September of 2020. Still a clinical-stage company at the time, Moderna had no authorized or approved products. That changed months later, when the U.S. Food and Drug Administration authorized Moderna’s Covid-19 vaccine, which is expected to bring in $20.1 billion in revenues this year alone.
Its stock price has been up more than 300% this year. 

Just to mention, another vaccine maker $NVAX.US$ had also initiated an early-stage study to test its combined flu and COVID-19 vaccine. However, the same scenario didn't show on its stock price. Kinda tricky.
Disclaimer: Moomoo Technologies Inc. is providing this content for information and educational use only. Read more
1
2
2
1
33
+0
17
Translate
Report
117K Views
Comment
Sign in to post a comment
avatar
Moomoo Community Official Account
Bringing you insights, inspiration and the hottest content.
151KFollowers
1201Following
61KVisitors
Follow